A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy

Ke Gong; Zhiping Tan; Haidan Liu; Xiaobo Liao; Xinmin Zhou; Bangliang Yin; Shi Zeng; Yao Yao; Yifeng Yang; Li Xie

doi:10.1016/j.gendis.2023.02.040

您当前的位置：

首页 >

文章列表页 >

A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy

Rapid Communications | 更新时间：2024-02-04

- A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy
- A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy
- Genes & Diseases 2024年1卷第1期页码：84-86
- 作者机构：
  
  1. Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Central South University,Hunan,Changsha,China,410011
  2. Department of Ultrasound, The Second Xiangya Hospital of Central South University, Central South University,Hunan,Changsha,China,410011
  3. Department of Blood Transfusion, The Second Xiangya Hospital of Central South University, Central South University,Hunan,Changsha,China,410011
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.02.040
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-1-1，
扫描看全文
A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy[J]. Genes & Diseases, 2024,1(1):84-86.

Ke Gong, Zhiping Tan, Haidan Liu, et al. A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy[J]. Genes & Diseases, 2024,1(1):84-86.
A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy[J]. Genes & Diseases, 2024,1(1):84-86. DOI： 10.1016/j.gendis.2023.02.040.

Ke Gong, Zhiping Tan, Haidan Liu, et al. A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy[J]. Genes & Diseases, 2024,1(1):84-86. DOI： 10.1016/j.gendis.2023.02.040.

摘要

Abstract

关键词

Keywords

references

1 R.G. Weintraub, C. Semsarian, P. MacDonaldDilated cardiomyopathy Lancet, 390 (10092) (2017), pp. 400-414

2 A.K. Sharma, P.V. Thanikachalam, S. BhatiaThe signaling interplay of GSK-3β in myocardial disorders Drug Discov Today, 25 (4) (2020), pp. 633-641

3 B.W. Doble, S. Patel, G.A. Wood, et al.Functional redundancy of GSK-3 alpha and GSK-3 beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines Dev Cell, 12 (6) (2007), pp. 957-971

4 M.J. Stachowski-Doll, M. Papadaki, T.G. Martin, et al.GSK-3β localizes to the cardiac Z-disc to maintain length dependent activation Circ Res, 130 (6) (2022), pp. 871-886

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据